{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:45:42Z","timestamp":1668750342627},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:p>A 66-year-old woman with chronic hepatitis B infection and hepatocellular carcinoma presented with moderate radiating epigastric pain with nausea, anorexia, and water brash without emesis. What is your diagnosis?<\/jats:p>","DOI":"10.1001\/jamaoncol.2022.3888","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T15:34:23Z","timestamp":1663860863000},"page":"1688","source":"Crossref","is-referenced-by-count":0,"title":["Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular Carcinoma"],"prefix":"10.1001","volume":"8","author":[{"given":"Binbin","family":"Zheng-Lin","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Medical College of Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Faleck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Medical College of Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Medical College of Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"ccg220003r1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459).","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"issue":"20","key":"ccg220003r2","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"ccg220003r3","first-page":"971","article-title":"Evaluation of acute abdominal pain in adults.","volume":"77","author":"Cartwright","year":"2008","journal-title":"Am Fam Physician"},{"issue":"7","key":"ccg220003r4","first-page":"3511","article-title":"Second primary malignancies in hepatocellular cancer\u2014a US population-based study.","volume":"36","author":"Shah","year":"2016","journal-title":"Anticancer Res"},{"issue":"3","key":"ccg220003r5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ncpgasthep1356","article-title":"Pathogenesis of portal hypertensive gastropathy.","volume":"6","author":"Perini","year":"2009","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"1","key":"ccg220003r6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s40425-019-0779-6","article-title":"Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI.","volume":"7","author":"Xing","year":"2019","journal-title":"J Immunother Cancer"},{"key":"ccg220003r7","doi-asserted-by":"crossref","DOI":"10.1177\/11795549211028570","article-title":"Immunotherapy-related gastritis.","volume":"15","author":"Woodford","year":"2021","journal-title":"Clin Med Insights Oncol"},{"issue":"7","key":"ccg220003r8","doi-asserted-by":"crossref","first-page":"E982","DOI":"10.1055\/a-1839-4303","article-title":"Severe immune checkpoint inhibitor-associated gastritis.","volume":"10","author":"Sugiyama","year":"2022","journal-title":"Endosc Int Open"},{"issue":"5","key":"ccg220003r9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/00365521.2019.1594356","article-title":"Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors.","volume":"54","author":"Tang","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"ccg220003r10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1158\/2326-6066.CIR-17-0755","article-title":"Safety and efficacy of re-treating with immunotherapy after immune-related adverse events in patients with NSCLC.","volume":"6","author":"Santini","year":"2018","journal-title":"Cancer Immunol Res"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2796772\/jamaoncology_zhenglin_2022_cg_220003_1668658034.02186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:03:25Z","timestamp":1668701005000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2796772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2022.3888","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}